# JEFFERIES FINANCIAL SERVICES, INC. X-17A-5/A (2025-01-31) — Broker-dealer annual report

- Company: JEFFERIES FINANCIAL SERVICES, INC.
- Form: X-17A-5/A
- Filed: 2025-01-31
- Period: 2024-11-30
- Accession: 0001891399-25-000003
- CIK: 1891399
- File #: 8-70821
- Type: Broker-dealer
- Material weakness: No
- Auditor: Deloitte Touche LLP
- Auditor location: NEW YORK, NY
- Contact: Robert Matos
- Phone: 212-284-2137
- Email: awhite@jefferies.com
- Website: jefferies.com
- Signed by: Andrew White (Chief Financial Officer)

Original filing: https://www.sec.gov/Archives/edgar/data/1891399/000189139925000003/jfsi2024public.pdf

---

{0}------------------------------------------------

#### **Jefferies Financial Services, Inc.**

#### (SEC I.D No. 026-00164)

Statement of Financial Condition as of November 30, 2024 and Independent Auditor's Report

\*\*\*\*\*\*

Filed pursuant to Rule 18a-7(d)(2) under the Securities Exchange Act of 1934 and Regulation 23.105(e) under the Commodity Exchange Act as a Public Document.

{1}------------------------------------------------

# **UNITED STATES** 0MB APPROVAL **SECURITIES AND EXCHANGE COMMISSION** 0MB Number: ........ 3235-0123 **Washington, D.C. 20549** Expires: ........... November 30, 2026

Estimated average burden hours per response: .............. 12

| SEC FILE NUMBER |  |
|-----------------|--|
|                 |  |

# **ANNUAL REPORTS** SEC FILE NUMBER **FORM X-17A-5** 026-00164 **PART** III

# **FACING PAGE**

**Information Required Pursuant to Rules 17a-5, 17a-12, and 18a-**7 **under the Securities Exchange Act of 1934** 

| FILING FOR THE PERIOD<br>BEGINNING | 12/1/2023 | AND<br>ENDING | 11/30/2024 |
|------------------------------------|-----------|---------------|------------|
|                                    | MM/DDNY   |               | MM/DDNY    |

# **A.REGISTRANT IDENTIFICATION**

NAME OF FIRM: Jefferies Financial Services, Inc.

TYPE OF REGISTRANT (check all applicable boxes):

□ Broker-dealer ~ Security-based swap dealer □ Major security-based swap participant

<sup>~</sup>Check here if respondent is also an OTC derivatives dealer

# ADDRESS OF PRINCIPAL PLACE OF BUSINESS: (Do not use a P.O. box no.)

| 520 Madison A venue |  |
|---------------------|--|
|                     |  |

|                       | (No. and Street)                                                                               |                 |                      |
|-----------------------|------------------------------------------------------------------------------------------------|-----------------|----------------------|
| New York              | New York                                                                                       | 10022           |                      |
| (City)                | (State)                                                                                        |                 | (Zip Code)           |
|                       |                                                                                                |                 |                      |
|                       | PERSON TO CONTACT WITH REGARD TO THIS FILING                                                   |                 |                      |
| Andrew White          | (201) 761-8976                                                                                 |                 | awhite@jefferies.com |
| (Name)                | (Area Code-Telephone Number)                                                                   | (Email Address) |                      |
|                       | B.ACCOUNTANT IDENTIFICATION                                                                    |                 |                      |
|                       | INDEPENDENT PUBLIC ACCOUNTANT whose reports are contained in this filing*                      |                 |                      |
| Deloitte & Touche LLP |                                                                                                |                 |                      |
|                       | (Name-if individual, state last, first, and middle name)                                       |                 |                      |
| 30 Rockefeller Plaza  | New York                                                                                       | New York        | 10112                |
| (Address)             | (City)                                                                                         | (State)         | (Zip Code)           |
| 10/20/2003            |                                                                                                | # 34            |                      |
|                       | (Date of Registration with PCAOB)(if applicable)<br>(PCAOB Registration Number, if applicable) |                 |                      |
| FOR OFFICIAL USE ONLY |                                                                                                |                 |                      |

\* Claims for exemption from the requirement that the annual reports be covered by the reports of an independent public accountant must be supported by a statement of facts and circumstances relied on as the basis of the exemption. See l 7CFR 240. l 7a-5(e)(l)(ii), if applicable.

**Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid 0MB control number.** 

{2}------------------------------------------------

#### **Affirmation**

I, Andrew White, affirm that, to the best of my knowledge and belief, the accompanying financial statements and supplemental schedule pertaining to the firm of Jefferies Financial Services, Inc., as of and for the year ended November 30, 2024, are true and correct. I further affirm that neither the company nor any officer or director has any proprietary interest in any account classified solely as that of a customer.

Signature:

~ - Title:

Chief Financial Officer

Notary Public

MEGAN MAHER NOTARY PUBLIC, STATE OF NEW YORK Registration No. OIMA0028512 Qualified in New York County Commission Expires 09/05/2028

{3}------------------------------------------------

# **This filingtt- contains (check all applicable boxes):**

- I;:'! (a) Statement of financial condition.
- I;:'! (b) Notes to statement of financial condition.
- D (c) Statement of operations
- D ( d) Statement of cash flows.
- D (e) Statement of changes in stockholder's equity.
- D (f) Statement of changes in liabilities subordinated to claims of general creditors.
- D (g) Notes to financial statements.
- D (h) Computation of net capital under 17 CFR 240.15c3-1 or 17 CFR 240.1 Sa-1, as applicable.
- D (i) Computation of tangible net worth under 17 CFR 240.1 Sa-2.
- D 0) Computation for determination of customer reserve requirements pursuant to Exhibit A to 17 CFR 240.15c3-3.
- D (k) Computation for determination of security-based swap reserve requirements pursuant to Exhibit B to 17 CFR 240.15c3-3 or Exhibit A to 17 CFR 240.1 Sa-4, as applicable.
- D (I) Computation for Determination of PAB Requirements under Exhibit A to§ 240.15c3-3.
- D (m) Information relating to possession or control requirements for customers under 17 CFR 240.15c3-3.
- D (n) Information relating to possession or control requirements for security-based swap customers under 17 CFR 240.15c3-3(p )(2) or 17 CFR 240.1 Sa-4, as applicable.
- D (o) Reconciliations, including appropriate explanations, of the FOCUS Report with computation of net capital or tangible net worth under 17 CFR 240.15c3-1, 17 CFR 240.1 Sa-1, or 17 CFR 240.1 Sa-2, as applicable, and the reserve requirements under 17 CFR 240.15c3-3 or 17 CFR 240.1 Sa-4, as applicable, if material differences exist, or a statement that no material differences exist.
- D (p) Summary of financial data for subsidiaries not consolidated in the statement of financial condition.
- I;:'! (q) Oath or affirmation in accordance with 17 CFR 240.17a-5, 17 CFR 240.17a-12, or 17 CFR 240.1 Sa-7, as applicable.
- D (r) Compliance report in accordance with 17 CFR 240.17a-5 or 17 CFR 240.1 Sa-7, as applicable.
- D (s) Exemption report in accordance with 17 CFR 240.17a-5 or 17 CFR 240.1 Sa-7, as applicable.
- I;:'! (t) Independent public accountant's report based on an examination of the statement of financial condition.
- D (u) Independent public accountant's report based on an examination of the financial report or financial statements under 17 CFR 240.17a-5, 17 CFR 240.18a-7, or 17 CFR 240.17a-12, as applicable.
- D (v) Independent public accountant's report based on an examination of certain statements in the compliance report under 17 CFR 240.17a-5 or 17 CFR 240.18a-7, as applicable.
- D (w) Independent public accountant's report based on a review of the exemption report under 17 CFR 240.17a-5 or 17 CFR 240.1 Sa-7, as applicable.
- D (x) Supplemental reports on applying agreed-upon procedures, in accordance with 17 CFR 240.15c3-1 e or 17 CFR 240.17a-12, as applicable.
- D (y) Report describing any material inadequacies found to exist or found to have existed since the date of the previous audit, or a statement that no material inadequacies exist, under 17 CFR 240.17a-12(k).
- D (z) Other:

tt-To request confidential treatment of certain portions of this filing, see 17 CFR 240.17a-5(e)(3) or 17 CFR 240.18a-7(d)(2), as applicable.

{4}------------------------------------------------

# **Deloitte.**

Deloitte & Touche **LLP**  30 Rockefeller Plaza New York, NY 10112 Tel: +l 212-492-4000 www.deloitte.com

# **INDEPENDENT AUDITOR'S REPORT**

To the Board of Directors and Stockholder of Jefferies Financial Services, Inc.

We have audited the accompanying statement of financial condition of Jefferies Financial Services, Inc. (the "Company"), as of November 30, 2024, and the related notes to the statement of financial condition (collectively referred to as the "financial statements").

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of November 30, 2024, in accordance with accounting principles generally accepted in the United States of America.

# **Basis for Opinion**

We conducted our audit in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audit. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

# **Responsibilities of Management for the Financial Statements**

Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are issued.

# **Auditor's Responsibilities for the Audit of the Financial Statements**

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

{5}------------------------------------------------

In performing an audit in accordance with GAAS, we:

- Exercise professional judgment and maintain professional skepticism throughout the audit.
- Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.
- Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.
- Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

January 28, 2025

{6}------------------------------------------------

# **Statement of Financial Condition**

| \$ in thousands                                                                      | November 30, 2024 |
|--------------------------------------------------------------------------------------|-------------------|
| Assets                                                                               |                   |
| Cash and cash equivalents                                                            | \$<br>1,654,803   |
| Financial instruments owned, at fair value (includes \$21,837 of securities pledged) | 1,823,662         |
| Securities purchased under agreements to resell .                                    | 282,248           |
| Receivables:                                                                         |                   |
| Brokers, dealers and clearing organizations                                          | 484,116           |
| Fees, interest and other                                                             | 8,932             |
| Due from affiliates                                                                  | 240               |
| Premises and equipment                                                               | 111               |
| Other assets                                                                         | 8,252             |
| Total assets  \$                                                                     | 4,262,364         |

#### **Liabilities and Stockholder's Equity**

| Financial instruments sold, not yet purchased, at fair value                         |  | 1,690,761 |
|--------------------------------------------------------------------------------------|--|-----------|
| Securities loaned                                                                    |  | 2,179     |
| Securities sold under agreements to repurchase                                       |  | 6,360     |
| Payables:                                                                            |  |           |
| Brokers, dealers and clearing organizations                                          |  | 1,376,867 |
| Due to Parent and affiliates                                                         |  | 324,974   |
| Accrued expenses and other liabilities                                               |  | 11,076    |
| Total liabilities  .                                                                 |  | 3,412,217 |
| Subordinated liabilities                                                             |  | 600,000   |
| Stockholder's equity                                                                 |  |           |
| Class A common stock, \$2 par value; authorized, issued and outstanding 1,000 shares |  | 2         |
| Additional paid-in-capital                                                           |  | 290,371   |
| Retained deficit                                                                     |  | (40,226)  |
| Total stockholder's equity  .                                                        |  | 250,147   |
| Total liabilities and stockholder's equity  \$                                       |  | 4,262,364 |

See accompanying notes to Statement of Financial Condition.

{7}------------------------------------------------

## **Note 1. Organization and Basis of Presentation**

#### **Organization and Business**

Jefferies Financial Services, Inc. (the "Company"), an entity incorporated in the State of Delaware, engages primarily as a market maker in Over-the-Counter ("OTC") derivative transactions and acts as a dealer in swap and security-based swap transactions to a broad range of clients including its affiliates. The Company is a wholly owned subsidiary of Jefferies Financial Group Inc. ("Jefferies" or the "Parent"), a diversified holding company incorporated in the state of New York and engaged in a variety of businesses. The Company operates and is managed as a single reportable business within the Capital Markets segment of Jefferies.

The Company is a registered OTC derivatives dealer and is conditionally registered as a security-based swap dealer with the Securities Exchange Commission ("SEC") and is subject to the SEC's regulatory rules and minimum net capital requirements. Furthermore, as a registered swap dealer with the Commodity Futures Trading Commission ("CFTC") and a member of the National Futures Association ("NFA"), the Company is also subject to the CFTC's regulatory rules and the minimum net capital requirements under both the CFTC and the NFA.

The Company is dependent on Jefferies LLC, a registered brokerdealer and subsidiary of the Parent, wherein Jefferies LLC employees provide the trade support, execution and settlement for transactions related to the Company's OTC derivatives and swaps business.

#### **Basis of Presentation**

The accompanying Statement of Financial Condition has been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). These principles require management to make a number of estimates and assumptions that may affect the amounts reported in the Statement of Financial Condition and accompanying notes. The most important of these estimates and assumptions relate to fair value measurements, related party transactions, compensation and benefits, and the accounting for income taxes. Although these and other estimates and assumptions are based on the best available information, actual results could be materially different from these estimates.

#### **Subsequent Events**

Management has evaluated events and transactions that occurred subsequent to November 30, 2024 through the date this Statement of Financial Condition was issued, and determined there were no events or transactions during such period requiring recognition or disclosure in the Statement of Financial Condition, except as disclosed in Note 9, Liabilities Subordinated to Claims of General Creditors.

#### **Note 2. Significant Accounting Policies**

#### **Cash Equivalents**

Cash equivalents include highly liquid investments, including money market funds, not held for resale with original maturities of three months or less.

#### **Financial Instruments and Fair Value**

Financial instruments owned and Financial instruments sold, not yet purchased are recorded at fair value as required by accounting pronouncements. These instruments primarily represent the Company's trading activities and include both cash and derivative products. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price).

Fair Value Hierarchy. In determining fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability based on market data obtained from independent sources. Unobservable inputs reflect the assumptions that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The Company applies a hierarchy to categorize its fair value measurements broken down into three levels based on the transparency of inputs as follows:

- Level 1 Quoted prices are available in active markets for identical assets or liabilities at the reported date. Valuation adjustments and block discounts are not applied to Level 1 instruments.
- Level 2 Pricing inputs other than quoted prices in active markets, which are either directly or indirectly observable at the reported date. The nature of these financial instruments include cash instruments for which quoted prices are available but traded less frequently, derivative instruments for which fair values have been derived using model inputs that are directly observable in the market, or can be derived principally from, or corroborated by, observable market data, and instruments that are fair valued by using other financial instruments, the parameters of which can be directly observed.
- Level 3 Instruments that have little to no pricing observability at the reported date. These financial instruments are measured using management's best estimate of fair value, where the inputs into the determination of fair value require significant management judgment or estimation.

Certain financial instruments have bid and ask prices that can be observed in the marketplace. For financial instruments whose inputs are based on bid-ask prices, the financial instrument is valued at the point within the bid-ask range that meets the Company's best estimate of fair value. The Company uses prices and inputs that are current at the measurement date. For financial instruments that do not have readily determinable fair values using quoted market prices, the determination of fair value is based on the best available information, taking into account the types of financial instruments, current financial information, restrictions (if any) on dispositions, fair values of underlying financial instruments and quotations for similar instruments.

{8}------------------------------------------------

The valuation of financial instruments may include the use of valuation models and other techniques. Adjustments to valuations derived from valuation models are permitted based on management's judgment, which takes into consideration the features of the financial instrument such as its complexity, the market in which the financial instrument is traded and underlying risk uncertainties about market conditions. Adjustments from the price derived from a valuation model reflect management's judgment that other participants in the market for the financial instrument being measured at fair value would also consider in valuing that same financial instrument. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment.

The availability of observable inputs can vary and is affected by a wide variety of factors, including, for example, the type of financial instrument and market conditions. As the observability of prices and inputs may change for a financial instrument from period to period, this condition may cause a transfer of an instrument among the fair value hierarchy levels. The degree of judgment exercised in determining fair value is greatest for instruments categorized within Level 3.

# **Receivable from and Payable to Brokers, Dealers and Clearing Organizations**

Receivables from and payables to brokers, dealers and clearing organizations include deposits of cash and/or securities with exchange clearing organizations to meet margin requirements, amounts due to or from clearing organizations for daily variation settlements, receivables and payables for fees and commissions and net receivables or payables arising from unsettled security transactions.

# **Credit Losses on Financial Assets Measured at Amortized Cost**

Financial assets measured at amortized cost are presented at the net amount expected to be collected and the measurement of credit losses and any expected increases and decreases in expected credit losses are recognized in earnings. The estimate of expected credit losses involves judgment and is based on an assessment over the life of the financial instrument taking into consideration forecasts of expected future economic conditions. In evaluating secured financing receivables (reverse repurchase agreements, securities borrowing arrangements and margin loans), the underlying collateral maintenance provisions are taken into consideration. The underlying contractual collateral maintenance for significantly all of the Company's secured financing receivables requires that the counterparty continually adjust the collateralization amount, securing the credit exposure on these contracts. Collateralization levels for the Company's secured financing receivables are initially established based on the counterparty, the type of acceptable collateral that is monitored daily and adjusted to mitigate the potential of any credit losses. Credit losses are not recognized for secured financing receivables where the underlying collateral's fair value is equal to or exceeds the asset's amortized cost basis. In cases where the collateral's fair value does not equal the or exceed the amortized cost basis, the allowance for credit losses, if any, is limited to the difference between the fair value of the collateral at the reporting date and the amortized cost basis of the financial assets.

The Company's receivables from brokers, dealers, and clearing organizations include deposits of cash with exchange clearing organizations to meet margin requirements, amounts due from clearing organizations for daily variation settlements, securities failed-to-deliver or receive, receivables and payables for fees and commissions, and receivables arising from unsettled securities or loan transactions. These receivables generally do not give rise to material credit risk and have a remote probability of default either because of their short-term nature or due to the credit protection framework inherent in the design and operations of brokers, dealers and clearing organizations. As such, generally, no allowance for credit losses is held against these receivables.

For all other financial assets measured at amortized cost, the Company estimates expected credit losses over the financial assets' life as of the reporting date based on relevant information about past events, current conditions, and reasonable and supportable forecasts.

# **Securities Borrowed and Securities Loaned**

Securities borrowed and securities loaned are carried at the amounts of cash collateral advanced and received in connection with the transactions and accounted for as collateralized financing transactions. In connection with both trading and brokerage activities, the Company borrows securities to cover short sales and to complete transactions in which customers have failed to deliver securities by the required settlement date, and lends securities to other brokers and dealers for similar purposes. The Company has an active securities borrowed and lending matched book business in which it borrows securities from one party and lends them to another party. When the Company borrows securities, it generally provides cash to the lender as collateral, which is reflected in the Statement of Financial Condition as Securities borrowed. Similarly, when the Company lends securities to another party, that party provides cash to the Company as collateral, which is reflected in the Statement of Financial Condition as Securities loaned. The initial collateral advanced or received approximates or is greater than the fair value of the securities borrowed or loaned. The Company monitors the fair value of the securities borrowed and loaned on a daily basis and requests additional collateral or returns excess collateral, as appropriate. In instances where the Company receives securities as collateral in connection with securities-forsecurities transactions in the which the Company is the lender of securities and is permitted to sell or repledge the securities received as collateral, the Company reports the fair value of the collateral received and the related obligation to return the collateral in the Company's Statement of Financial Condition.

#### **Securities Purchased Under Agreements to Resell and Securities Sold Under Agreements to Repurchase**

Securities purchased under agreements to resell and Securities sold under agreements to repurchase (collectively "repos") are accounted for as collateralized financing transactions and are recorded at their contracted resale or repurchase amount plus accrued interest. Repos are presented in the Statement of Financial Condition on a net basis by counterparty, where permitted by U.S. GAAP. The Company monitors the fair value of the underlying securities daily versus the related receivable or payable balances. Should the fair value of the underlying securities decline or increase, additional collateral is requested or excess collateral is returned, as appropriate.

{9}------------------------------------------------

## **Offsetting of Derivative Financial Instruments and Securities Financing Agreements**

To manage the Company's exposure to credit risk associated with its derivative activities and securities financing transactions, the Company may enter into International Swaps and Derivative Association, Inc. ("ISDA") master netting agreements, master repurchase agreements or similar agreements and collateral arrangements with counterparties. A master agreement creates a single contract under which all transactions between two counterparties are executed allowing for trade aggregation and a single net payment obligation. Master agreements provide protection in bankruptcy in certain circumstances and, where legally enforceable, enable receivables and payables with the same counterparty to be settled or otherwise eliminated by applying amounts due against all or a portion of an amount due from the counterparty or a third party.

Under the Company's ISDA master netting agreements, it typically also executes credit support annexes, which provide for collateral, either in the form of cash or securities, to be posted by or paid to a counterparty based on the fair value of the derivative receivable or payable based on the rates and parameters established in the credit support annex.

In the event of the counterparty's default, provisions of the master agreement permit acceleration and termination of all outstanding transactions covered by the agreement such that a single amount is owed by, or to, the non-defaulting party. In addition, any collateral posted can be applied to the net obligations, with any excess returned; and the collateralized party has a right to liquidate the collateral. Any residual claim after netting is treated along with other unsecured claims in bankruptcy court.

The conditions supporting the legal right of offset may vary from one legal jurisdiction to another and the enforceability of master netting agreements and bankruptcy laws in certain countries or in certain industries is not free from doubt. The right of offset is dependent both on contract law under the governing arrangement and consistency with the bankruptcy laws of the jurisdiction where the counterparty is located. Industry legal opinions with respect to the enforceability of certain standard provisions in respective jurisdictions are relied upon as a part of managing credit risk. In cases where the Company has not determined an agreement to be enforceable, the related amounts are not offset. Master netting agreements are a critical component of the Company's risk management processes as part of reducing counterparty credit risk and managing liquidity risk.

#### **Intangible Assets**

An intangible asset with an indefinite useful life is not amortized but assessed for impairment annually, or more frequently, when events or changes in circumstances occur indicating that it is more likely than not that the indefinite-lived asset is impaired. Impairment exists when the carrying amount exceeds its fair value. In testing for impairment, the Company has the option to first perform a qualitative assessment to determine whether it is more likely than not that an impairment exists. **If** it is determined that it is not more likely than not that an impairment exists, a quantitative impairment test is not necessary. **If** it is concluded

otherwise, the Company is required to perform a quantitative impairment test.

Intangible assets are included in Other assets in the Statement of Financial Condition. The Company's annual indefinite-lived intangible asset impairment testing date is August 1s t . To the extent an impairment loss is recognized, the loss establishes the new cost basis of the asset that is amortized over the remaining useful life of that asset, if any. Subsequent reversal of impairment losses is not permitted.

#### **Income Taxes**

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The realization of deferred tax assets is assessed and a valuation allowance is recorded to the extent that it is more likely than not that any portion of the deferred tax asset will not be realized.

Per the tax sharing agreement between the Parent and the Company, the Parent records unrecognized tax benefits for positions it takes on the consolidated federal and any combined state and local tax returns and assumes the potential risk or benefit arising from the establishment of such unrecognized tax benefits.

#### **Legal Reserves**

In the normal course of business, the Company has been named, from time to time, as a defendant in legal and regulatory proceedings. The Company is also involved, from time to time, in other exams, investigations and similar reviews (both formal and informal) by governmental and self-regulatory agencies regarding its businesses, certain of which may result in judgments, settlements, fines, penalties or other injunctions.

The Company recognizes a liability for a contingency in Accrued expenses and other liabilities when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. **If** the reasonable estimate of a probable loss is a range, the Company accrues the most likely amount of such loss, and if such amount is not determinable, then the Company accrues the minimum in the range as the loss accrual. The determination of the outcome and loss estimates requires significant judgment on the part of management. The Company believes that any other matters for which it has determined a loss to be probable and reasonably estimable are not material to the Statement of Financial Condition.

In many instances, it is not possible to determine whether any loss is probable or even possible or to estimate the amount of any loss or the size of any range of loss. Management believes that, in the aggregate, the pending legal actions or regulatory proceedings and any other exams, investigations or similar reviews (both formal and informal) should not have a material adverse effect on the Statement of Financial Condition. In addition, management believes that any amount of potential loss or range of potential loss in excess of what has been provided in the Statement of Financial Condition that could be reasonably estimated is not material.

{10}------------------------------------------------

#### **Accounting Standards to be Adopted in Future Periods**

Segment Reporting. In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07 ("ASU 2023-07"), Improvements to Reportable Segment Disclosures. The guidance primarily will require enhanced disclosures about significant segment expenses. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, with early adoption permitted, and are to be applied on a retrospective basis. The Company is evaluating the impact of the standard on its segment reporting disclosures.

Income Taxes. In December 2023, the FASB issued ASU No. 2023-09 ("ASU 2023-09"), Improvements to Income Tax Disclosures. The guidance is intended to improve income tax disclosure requirements by requiring (i) consistent categories and greater disaggregation of information in the rate reconciliation and (ii) the disaggregation of income taxes paid by jurisdiction. The guidance makes several other changes to the income tax disclosure requirements. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024, with early adoption permitted, and is required to be applied prospectively with the option of retrospective application. The Company is evaluating the impact of the standard on its income tax disclosures.

#### **Note 3. Cash and Cash Equivalents**

Financial assets classified as cash and cash equivalents that are deemed by the Company's management to be generally readily convertible into cash:

| \$ in thousands                     | November 30, 2024 |           |  |  |  |
|-------------------------------------|-------------------|-----------|--|--|--|
| Cash in banks                       | \$                | 713,803   |  |  |  |
| Money market investments            |                   | 941,000   |  |  |  |
| Total cash and cash equivalents  \$ |                   | 1,654,803 |  |  |  |

#### **Note 4. Fair Value Disclosures**

The following is a summary of the Company's financial assets and liabilities that are accounted for at fair value on a recurring basis by level within the fair value hierarchy:

|                                                                  | November 30, 2024 |           |  |         |    |                                                       |              |  |
|------------------------------------------------------------------|-------------------|-----------|--|---------|----|-------------------------------------------------------|--------------|--|
| \$ in thousands                                                  | Level 1           | Level 2   |  | Level 3 |    | Counterparty<br>and Cash<br>Collateral<br>Netting (1) | Total        |  |
| Assets:                                                          |                   |           |  |         |    |                                                       |              |  |
| Financial instruments<br>owned:                                  |                   |           |  |         |    |                                                       |              |  |
| Corporate equity<br>securities                                   | \$ 1.658.737 \$   | 45 \$     |  | -       | \$ | -                                                     | \$ 1.658.782 |  |
| U.S. government<br>securities                                    | 25.524            |           |  |         |    |                                                       | 25.524       |  |
| Derivatives                                                      | -                 | 2.675.080 |  | 15.150  |    | (2.550.87 4)                                          | 139.356      |  |
| Total financial<br>instruments owned  \$1,684,261 \$2,675,125 \$ |                   |           |  |         |    | 15,150 \$ (2,550,874) \$1,823,662                     |              |  |
|                                                                  |                   |           |  |         |    |                                                       |              |  |
| Liabilities:                                                     |                   |           |  |         |    |                                                       |              |  |
| Financial instruments<br>sold. not yet purchased:                |                   |           |  |         |    |                                                       |              |  |

| Total financial<br>instruments sold,<br>notyetpurchased  \$ 950,407 \$3,100,726 \$ |               |           |         | 25,796 \$ (2,386,168) \$1,690,761 |            |
|------------------------------------------------------------------------------------|---------------|-----------|---------|-----------------------------------|------------|
| Derivatives                                                                        | -             | 2.655.276 | 25.796  | (2,386.168)                       | 294.904    |
| U.S. government<br>securities                                                      | 151.591       |           |         |                                   | 151.591    |
| Corporate debt securities                                                          |               | 445.450   |         |                                   | 445.450    |
| Corporate equity<br>securities                                                     | \$ 798.816 \$ | -         | \$<br>- | \$<br>-                           | \$ 798.816 |

(1) Represents counterparty and cash collateral netting across the levels of the fair value hierarchy for positions with the same counterparty.

The following is a description of the valuation basis, including valuation techniques and inputs, used in measuring the Company's financial assets and liabilities that are accounted for at fair value on a recurring basis:

#### Corporate Equity Securities

- Exchange-Traded Equity Securities: Exchange-traded equity securities are measured based on quoted closing exchange prices, which are generally obtained from external pricing services, and are categorized within Level 1 of the fair value hierarchy, otherwise they are categorized within Level 2 of the fair value hierarchy. To the extent these securities are actively traded, valuation adjustments are not applied.
- Non-Exchange-Traded Equity Securities: Non-exchange-traded equity securities are measured, where available using broker quotations, pricing data from external pricing services and prices observed from recently executed market transactions and are categorized within Level 2 of the fair value hierarchy. Where such information is not available, non-exchange-traded equity securities are categorized within Level 3 of the fair value hierarchy and measured using valuation techniques involving quoted prices of or market data for comparable companies, similar company ratios and multiples (e.g., price/Earnings before interest, taxes, depreciation and amortization ("EBITDA"), price/book value), discounted cash flow analyses and transaction prices observed from subsequent financing or capital issuance by the company. When using pricing data of comparable companies, judgment must be applied to adjust the pricing data to account for differences between the measured security and the comparable security (e.g., issuer

{11}------------------------------------------------

market capitalization, yield, dividend rate, geographical concentration).

Corporate Debt Securities

- Investment Grade Corporate Bonds: Investment grade corporate bonds are measured primarily using pricing data from external pricing services and broker quotations, where available, prices observed from recently executed market transactions and bond spreads. Investment grade corporate bonds measured using these valuation methods are categorized within Level 2 of the fair value hierarchy. If broker quotes, pricing data or spread data is not available, alternative valuation techniques may be used. Investment grade corporate bonds measured using alternative valuation techniques are categorized within Level 2 or Level 3 of the fair value hierarchy.
- High Yield Corporate and Convertible Bonds: All of the Company's high yield corporate and convertible bonds are categorized within Level 2 of the fair value hierarchy and are measured primarily using broker quotations and pricing data from external pricing services, where available, and prices observed from recently executed market transactions of institutional size.

# U.S. Government Securities

U.S. Treasury Securities: U.S. Treasury securities are measured based on quoted market prices obtained from external pricing services and categorized within Level 1 of the fair value hierarchy.

# Derivatives

- Listed Derivative Contracts: Listed derivative contracts that are actively traded are measured based on quoted exchange prices, broker quotes or vanilla option valuation models, such as Black-Scholes, using observable valuation inputs from the principal market or consensus pricing services. Exchange quotes and/or valuation inputs are generally obtained from external vendors and pricing services. Broker quotes are validated directly through observable and tradeable quotes. Listed derivative contracts that use exchange close prices are generally categorized within Level 1 of the fair value hierarchy. All other listed derivative contracts are generally categorized within Level 2 of the fair value hierarchy.
- Over-the-Counter ("OTC") Derivative Contracts: OTC derivative contracts are generally valued using models, whose inputs reflect assumptions that the Company believes market participants would use in valuing the derivative in a current transaction. Where available, valuation inputs are calibrated from observable market data. For many OTC derivative contracts, the valuation models do not involve material subjectivity as the methodologies do not entail significant judgment and the inputs to valuation models do not involve a high degree of subjectivity as the valuation model inputs are readily observable or can be derived from actively quoted markets. OTC derivative contracts are primarily categorized within Level 2 of the fair value hierarchy given the observability and significance of the inputs to the valuation models. Where significant inputs to the valuation are unobservable, derivative instruments are categorized within Level 3 of the fair value hierarchy.

OTC options include OTC equity, foreign exchange and interest rate options measured using various valuation models, such as Black-Scholes, with key inputs including the underlying security price, foreign exchange spot rate, implied volatility, interest rate curve, strike price and maturity date. Discounted cash flow models are utilized to measure certain OTC derivative contracts including the valuations of the Company's interest rate swaps, which incorporate observable inputs related to interest rate curves, and valuations of the Company's foreign exchange forwards, which incorporate observable inputs related to foreign currency spot rates and forward curves.

# **Quantitative Information about Significant Unobservable Inputs used in Level 3 Fair Value Measurements at November 30, 2024**

The table below presents information on the valuation technique, significant unobservable input and its range for the Company's financial assets and liabilities, subject to threshold levels related to the market value of the positions held, measured at fair value on a recurring basis with a significant Level 3 balance. The range of the unobservable input could differ significantly across different firms given the range of products across different firms in the financial services sector. The range of the input presented below should not be construed to represent uncertainty regarding the fair values of the Company's financial instruments; rather, the range of the input is reflective of the differences in the underlying characteristics of the financial instruments in the category.

The Company has provided a weighted average of the input allocated based on the fair values of the financial instruments comprising the category. The Company does not believe that the range or weighted average of the inputs is indicative of the reasonableness of uncertainty of its Level 3 fair values. The range and weighted average are driven by the individual financial instruments within the category and their relative distribution in the population. The disclosed input when compared with the inputs as disclosed in other periods should not be expected to necessarily be indicative of changes in the Company's estimates of unobservable inputs for a particular financial instrument as the population of financial instruments comprising the category will vary from period to period based on purchases and sales of financial instruments during the period as well as transfers into and out of Level 3 each period.

| Financial<br>Instruments Sold                    | Fair Value<br>(in thousands) | Valuation<br>Technique                | Significant<br>Unobservable<br>lnput(s) | Input/<br>Range | Weighted<br>Average |
|--------------------------------------------------|------------------------------|---------------------------------------|-----------------------------------------|-----------------|---------------------|
| Derivatives  \$                                  | 12.620                       |                                       |                                         |                 |                     |
| Options                                          |                              | Market<br>approach                    | Basis points<br>upfront                 | 0.3 - 22.3      | 14.6                |
| Financial Instruments Sold, Not<br>Yet Purchased |                              |                                       |                                         |                 |                     |
| Derivatives  \$                                  | 24.629                       |                                       |                                         |                 |                     |
| Options                                          |                              | Market<br>approach                    | Basis points<br>upfront                 | 8.0 - 22.3      | 14.9                |
| Equity options                                   |                              | Volatility<br>benchmarking Volatility |                                         | 28%-102%        | 49%                 |

At November 30, 2024, exclusions from the table above consisted of assets and liabilities of \$2.5 million and \$1.2 million, respectively, composed of certain derivatives.

{12}------------------------------------------------

# Uncertainty of Fair Value Measurement from Use of Significant Unobservable Inputs

For recurring fair value measurements categorized within Level 3 of the fair value hierarchy, the uncertainty of the fair value measurement to changes in significant unobservable inputs and interrelationships between those unobservable inputs (if any) are described below:

- Certain derivatives using a market approach valuation technique. Depending on whether we are a receiver or (payer) of basis points upfront, a significant increase in basis points would result in a significant increase (decrease) in the fair value measurement of options.
- Derivative equity options using volatility benchmarking. A significant increase (decrease) in volatility would result in a significantly higher (lower) fair value measurement.

#### **Financial Instruments Not Measured at Fair Value**

Certain of the Company's financial instruments are not carried at fair value but are recorded at amounts that approximate fair value due to their liquid or short-term nature and generally negligible credit risk. These financial assets include Cash and cash equivalents and would generally be presented within Level 1 of the fair value hierarchy.

Receivables - Brokers, dealers and clearing organizations, Receivables - Fees, interest and other, Receivables - Due from affiliates, Payables - Brokers, dealers and clearing organizations and Payables - Due to Parent and affiliates, are accounted for at cost plus accrued interest rather than fair value; however, the recorded amounts approximate fair value due to their liquid or short-term nature.

# **Note 5. Derivative Financial Instruments**

#### **Off-Balance Sheet Risk**

The Company has contractual commitments arising in the ordinary course of business for securities purchased under agreements to resell, or sold under repurchase agreements and future purchases and sales of foreign currencies. Each of these financial instruments and activities contains varying degrees of off-balance sheet risk whereby the fair values of the securities underlying the financial instruments may be in excess of, or less than, the contract amount. The settlement of these transactions is not expected to have a material effect on the Statement of Financial Condition.

# **Derivative Financial Instruments**

The Company's derivative activities are recorded at fair value in the Statement of Financial Condition in Financial instruments owned and Financial instruments sold, not yet purchased, net of cash paid or received under credit support agreements and on a net counterparty basis when a legally enforceable right to offset exists under a master netting agreement. The Company enters into derivative transactions to satisfy the needs of its clients and to manage its own exposure to market and credit risks resulting from its trading activities. (See Note 4, Fair Value Disclosures and Note 11, Guarantees for additional disclosures about derivative financial instruments.)

Derivatives are subject to various risks similar to other financial instruments, including market, credit and operational risk. The risks of derivatives should not be viewed in isolation, but rather should be considered on an aggregate basis along with the Company's other trading-related activities. The Company manages the risks associated with derivatives on an aggregate basis along with the risks associated with proprietary trading as part of its firm wide risk management policies.

In connection with its derivative activities, the Company may enter into ISDA master netting agreements or similar agreements with counterparties. See Note 2, Significant Accounting Policies for additional information regarding the offsetting of derivative contracts.

The following table also provides information regarding (1) the extent to which, under enforceable master netting arrangements, such balances are presented net in the Statement of Financial Condition as appropriate under U.S. GAAP and (2) the extent to which other rights of setoff associated with these arrangements exist and could have an effect on the Company's financial position. The fair value of assets/liabilities represents the Company's receivable/payable for derivative financial instruments, gross of counterparty netting and cash collateral received and pledged.

|                                                                   | November 30, 2024 (1) |                               |               |                               |  |  |  |  |  |
|-------------------------------------------------------------------|-----------------------|-------------------------------|---------------|-------------------------------|--|--|--|--|--|
|                                                                   | Assets                |                               | Liabilities   |                               |  |  |  |  |  |
| \$ in thousands                                                   | Fair Value            | Number of<br>Contracts<br>(2) | Fair Value    | Number of<br>Contracts<br>(2) |  |  |  |  |  |
| Equity contracts:                                                 |                       |                               |               |                               |  |  |  |  |  |
| Exchange-traded                                                   | \$<br>127,010         | 66,860 \$                     | 75,406        | 94,471                        |  |  |  |  |  |
| Bilateral OTC                                                     | 614,253               | 17,171                        | 910,037       | 17,166                        |  |  |  |  |  |
| Interest rate contracts:                                          |                       |                               |               |                               |  |  |  |  |  |
| Exchange-traded                                                   |                       | 63,432                        |               | 51,747                        |  |  |  |  |  |
| Cleared OTC                                                       | 1,006,404             | 6,097                         | 1,009,501     | 6,213                         |  |  |  |  |  |
| Bilateral OTC                                                     | 799,690               | 450                           | 542,817       | 299                           |  |  |  |  |  |
| Foreign exchange<br>contracts:                                    |                       |                               |               |                               |  |  |  |  |  |
| Bilateral OTC                                                     | 111,414               | 347                           | 102,691       | 328                           |  |  |  |  |  |
| Credit contracts:                                                 |                       |                               |               |                               |  |  |  |  |  |
| Cleared OTC                                                       | 31,439                | 37                            | 38,711        | 32                            |  |  |  |  |  |
| Bilateral OTC                                                     | 20                    |                               | 1,909         | 15                            |  |  |  |  |  |
| Total gross derivative<br>assets/liabilities:                     |                       |                               |               |                               |  |  |  |  |  |
| Exchange-traded                                                   | 127,010               |                               | 75,406        |                               |  |  |  |  |  |
| Cleared OTC                                                       | 1,037,843             |                               | 1,048,212     |                               |  |  |  |  |  |
| Bilateral OTC                                                     | 1,525,377             |                               | 1,557,454     |                               |  |  |  |  |  |
| Amounts offset in the<br>Statement of Financial<br>Condition (3): |                       |                               |               |                               |  |  |  |  |  |
| Exchange-traded                                                   | (74,590)              |                               | (74,590)      |                               |  |  |  |  |  |
| Cleared OTC                                                       | (1,037,776)           |                               | (1,045,062)   |                               |  |  |  |  |  |
| Bilateral OTC                                                     | (1,438,508)           |                               | (1,266,516)   |                               |  |  |  |  |  |
| Net amounts per<br>Statement of Financial<br>Condition (4)  \$    | 139,356               |                               | \$<br>294,904 |                               |  |  |  |  |  |

(1) Exchange-traded derivatives include derivatives executed on an organized exchange. Cleared OTC derivatives include derivatives executed bilaterally and subsequently novated to and cleared through central clearing counterparties. Bilateral OTC derivatives include derivatives executed and settled bilaterally without the use of an organized exchange or central clearing counterparty.

{13}------------------------------------------------

- (2) Number of exchange-traded contracts may include open futures contracts. The unsettled fair value of these futures contracts is included in Receivables from/Payables to brokers, dealers and clearing organizations in the Statement of Financial Condition.
- (3) Amounts netted include both netting by counterparty and for cash collateral paid or received.
- (4) The Company has not received or pledged additional collateral under master netting agreements and/or other credit support agreements that is eligible to be offset beyond what has been offset in the Statement of Financial Condition.

OTC Derivatives. Remaining contract maturity the fair value of OTC derivative assets and liabilities at November 30, 2024:

OTC **Derivative** Assets (1) (2) (3)

| \$ in thousands                                                                  | O -12 Months<br>1 - 5 Years |  |            | Greater Than<br>5 Years |            |    | Cross<br>Maturii<br>Netting 4) | Total     |  |
|----------------------------------------------------------------------------------|-----------------------------|--|------------|-------------------------|------------|----|--------------------------------|-----------|--|
| Equity options and<br>forwards                                                   | \$<br>65,309 \$             |  | 359 \$     |                         | -          | \$ | (244) \$                       | 65,424    |  |
| Total return swaps                                                               | 147,342                     |  | 31,544     |                         |            |    | (2,277)                        | 176,609   |  |
| Foreign currency<br>swaps and<br>forwards                                        | 93,023                      |  | 1,773      |                         |            |    |                                | 94,796    |  |
| Interest rate swaps,<br>options and<br>forwards                                  | 54,509                      |  | 197,127    |                         | 466,864    |    | (45,252)                       | 673,248   |  |
| Total                                                                            | \$<br>360,183 \$            |  | 230,803 \$ |                         | 466,864 \$ |    | (47,773)                       | 1,010,077 |  |
| Cross-product<br>counterparty netting                                            |                             |  |            |                         |            |    |                                | (66,868)  |  |
| Total OTC<br>derivatives assets<br>included in<br>Financial<br>instruments owned |                             |  |            |                         |            |    |                                | 943,209   |  |

(1) At November 30, 2024, the Company held exchange-traded derivative assets with a fair value of \$52.4 million, which are not included in this table.

(2) OTC derivative assets in the table above are gross of collateral received. OTC derivative assets are recorded net of collateral received in the Statement of Financial Condition. At November 30, 2024, cash collateral received was \$856.3 million.

(3) Derivative fair values include counterparty netting within product category.

(4) Amounts represent the netting of receivable balances with payable balances for the same counterparty within product category across maturity categories.

|                                                                                                            | OTC Derivative Liabilities (1) (2) (3) |             |                         |                                |           |  |  |  |  |  |
|------------------------------------------------------------------------------------------------------------|----------------------------------------|-------------|-------------------------|--------------------------------|-----------|--|--|--|--|--|
| \$ in thousands                                                                                            | O -12 Months                           | 1 - 5 Years | Greater Than<br>5 Years | Cross<br>Maturii<br>Netting 4) | Total     |  |  |  |  |  |
| Equity options and<br>forwards                                                                             | \$<br>146,437 \$                       | 121,815 \$  | -                       | \$<br>(244) \$                 | 268,008   |  |  |  |  |  |
| Credit default<br>swaps                                                                                    | 1,408                                  | 730         | 7,023                   |                                | 9,161     |  |  |  |  |  |
| Total return swaps                                                                                         | 196,225                                | 75,860      |                         | (2,277)                        | 269,808   |  |  |  |  |  |
| Foreign currency<br>swaps and<br>forwards                                                                  | 85,001                                 | 1,073       |                         |                                | 86,074    |  |  |  |  |  |
| Interest rate swaps,<br>options and<br>forwards                                                            | 36,434                                 | 134,442     | 293,849                 | (45,252)                       | 419,473   |  |  |  |  |  |
| Total  \$                                                                                                  | 465,505 \$                             | 333,920 \$  | 300,872 \$              | (47,773)                       | 1,052,524 |  |  |  |  |  |
| Cross-product<br>counterparty netting                                                                      |                                        |             |                         |                                | (66,868)  |  |  |  |  |  |
| Total OTC<br>derivatives<br>liabilities included<br>in Financial<br>instruments sold,<br>not yet purchased |                                        |             |                         | \$                             | 985,656   |  |  |  |  |  |

(1) At November 30, 2024, the Company held exchange-traded derivative liabilities with a fair value of \$0.8 million, which are not included in this table.

- (2) OTC derivative liabilities in the table above are gross of collateral received. OTC derivative liabilities are recorded net of collateral pledged in the Statement of Financial Condition. At November 30, 2024, cash collateral pledged was \$691.6 million
- (3) Derivative fair values include counterparty netting within product category.
- (4) Amounts represent the netting of receivable balances with payable balances for the same counterparty within product category across maturity categories.

Counterparty credit quality with respect to the fair value of the Company's OTC derivative assets at November 30, 2024 (in thousands):

#### **Counterparty credit quality (1** ):

| A- or higher | \$<br>151,465 |
|--------------|---------------|
| BBB- to BBB+ | 507,747       |
| BB+ or lower | 230,664       |
| Unrated      | 53,333        |
| Total  \$    | 943,209       |

(1) The Company utilizes internal credit ratings determined by its Risk Management department. Credit ratings determined by Risk Management use methodologies that produce ratings generally consistent with those produced by external rating agencies.

#### **Credit Related Derivative Contracts**

The external credit ratings of the underlyings or referenced assets for the Company's written credit related derivative contracts:

|                               | November 30, 2024                                 |          |  |          |                   |       |  |  |  |
|-------------------------------|---------------------------------------------------|----------|--|----------|-------------------|-------|--|--|--|
|                               | External Credit Rating                            |          |  |          |                   |       |  |  |  |
| \$ in millions                | Non<br>Investment<br>investment<br>Grade<br>Grade |          |  |          | Total<br>Notional |       |  |  |  |
| Credit protection sold:       |                                                   |          |  |          |                   |       |  |  |  |
| Index credit default<br>swaps | \$                                                | 374.0 \$ |  | 374.0 \$ |                   | 748.0 |  |  |  |

#### **Contingent Features**

Certain of the Company's derivative instruments contain provisions that require its debt to maintain an investment grade credit rating from each of the major credit rating agencies. If the Parent's debt were to fall below investment grade, it would be in violation of these provisions and the counterparties to the derivative instruments could request immediate payment or demand immediate and ongoing full overnight collateralization on the Company's derivative instruments in liability positions. The following table presents the aggregate fair value of all derivative instruments with such credit-risk-related contingent features that are in a liability position, the collateral amounts the Company has posted or received in the normal course of business and the potential collateral it would have been required to return and/or post additionally to its counterparties if the credit-risk-related contingent features underlying these agreements were triggered:

| \$ in millions                                                                    | November 30, 2024 |        |  |
|-----------------------------------------------------------------------------------|-------------------|--------|--|
| Derivative instrument liabilities with credit-risk<br>related contingent features | \$                | 74.7   |  |
| Collateral posted                                                                 |                   | (31.9) |  |
| Collateral received                                                               |                   | 270.9  |  |
| event of a credit rating downgrade be.low<br>investment grade (1)                 |                   | 313.7  |  |

(1) These potential outflows include initial margin received from counterparties at the execution of the derivative contract. The initial margin will be returned if counterparties elect to terminate the contract after a downgrade.

#### **Note 6. Collateralized Transactions**

The Company's repurchase agreements and securities lending arrangements are generally recorded at cost in the Statement of Financial Condition, which is a reasonable approximation of their

{14}------------------------------------------------

fair values due to their short-term nature. The Company monitors its exposure to credit risk associated with these transactions by entering into master netting agreements. The Company pledges securities as collateral under these secured arrangements. The agreements with counterparties generally contain contractual provisions allowing the counterparty the right to sell or repledge the collateral.

Carrying value of securities lending arrangements and repurchase agreements by class of collateral pledged and remaining contractual maturity at November 30, 2024:

| \$ in thousands                                  |    | Securities<br>Lending<br>Arrangements | Repurchase<br>Agreements | Total |        |  |
|--------------------------------------------------|----|---------------------------------------|--------------------------|-------|--------|--|
| Collateral Pledged:                              |    |                                       |                          |       |        |  |
| Corporate equity securities                      | \$ | 2,179 \$                              | -                        | \$    | 2,179  |  |
| U.S. government and federal<br>agency securities |    |                                       | 21,837                   |       | 21,837 |  |
| Total  \$                                        |    | 2,179 \$                              | 21,837 \$                |       | 24,016 |  |

|                                           | Contractual Maturity           |           |                  |   |    |               |    |                            |    |        |  |
|-------------------------------------------|--------------------------------|-----------|------------------|---|----|---------------|----|----------------------------|----|--------|--|
|                                           | Overnight<br>and<br>Continuous |           | Up to 30<br>Days |   |    | 31-90<br>Days |    | Greater<br>than 90<br>Days |    | Total  |  |
| Securities<br>lending<br>arrangements<br> | \$                             | 2,179 \$  |                  | - | \$ | -             | \$ | -                          | \$ | 2,179  |  |
| Repurchase<br>agreements                  |                                | 21,837    |                  |   |    |               |    |                            |    | 21,837 |  |
| Total  \$                                 |                                | 24,016 \$ |                  |   | \$ |               | \$ |                            | \$ | 24,016 |  |

The Company receives securities as collateral under securities lending arrangements and resale agreements. In many instances, the Company is permitted by contract to rehypothecate the securities received as collateral. These securities may be used to secure repurchase agreements, satisfy margin requirements on derivative transactions or cover short positions.

#### Offsetting of Securities Financing Agreements

To manage the Company's exposure to credit risk associated with securities financing transactions, it may enter into master netting agreements and collateral arrangements with counterparties. Generally, transactions are executed under standard industry agreements, including, but not limited to, master repurchase agreements. See Note 2, Significant Accounting Policies for additional information regarding the offsetting of securities financing agreements.

The following table provides information regarding repurchase agreements and securities lending arrangements that are recognized in the Statement of Financial Condition and (1) the extent to which, under enforceable master netting arrangements, such balances are presented net in the Statement of Financial Condition as appropriate under U.S. GAAP and (2) the extent to which other rights of setoff associated with these arrangements exist and could have an effect on the Company's financial position:

|                                       | November 30, 2024 |               |                                                         |             |                                                             |            |                                                      |            |           |              |                           |       |
|---------------------------------------|-------------------|---------------|---------------------------------------------------------|-------------|-------------------------------------------------------------|------------|------------------------------------------------------|------------|-----------|--------------|---------------------------|-------|
| \$ in thousands                       | Gross<br>Amounts  |               | Netting in<br>Statement<br>of<br>Financial<br>Condition |             | Net Amounts<br>in<br>Statement of<br>Financial<br>Condition |            | Additional<br>Amounts<br>Available for<br>Setoff (1) |            | Available |              | Collateral (2) Net Amount |       |
| Assets                                |                   |               |                                                         |             |                                                             |            |                                                      |            |           |              |                           |       |
| Reverse<br>repurchase<br>agreements   |                   | \$ 297,725 \$ |                                                         | (15,477) \$ |                                                             | 282,248 \$ |                                                      | (6,355) \$ |           | (273,962) \$ |                           | 1,931 |
| Liabilities                           |                   |               |                                                         |             |                                                             |            |                                                      |            |           |              |                           |       |
| Securities<br>lending<br>arrangements |                   | 2,179 \$      |                                                         | -           | \$                                                          | 2,179      |                                                      | -          | \$        | (2,179) \$   |                           |       |
| Repurchase<br>agreements              |                   | 21,837        |                                                         | (15,477)    |                                                             | 6,360      |                                                      | (6,355)    |           |              |                           |       |

- (1) Under master netting agreements with its counterparties, the Company has the legal right of offset with a counterparty, which incorporates all of the counterparty's outstanding rights and obligations under the arrangement. These balances reflect additional credit risk mitigation that is available by a counterparty in the event of a counterparty's default, but which are not netted in the balance sheet because other netting provisions of U.S. GAAP are not met.
- (2) Includes securities received or paid under collateral arrangements with counterparties that could be liquidated in the event of a counterparty default and thus offset against a counterparty's rights and obligations under the respective repurchase agreements or securities lending arrangements.

#### **Note 7. Receivables from, and Payable to, Brokers, Dealers and Clearing Organizations**

Major categories of receivables from, and payables to, brokers, dealers and clearing organizations at November 30, 2024:

| \$ in thousands                      |    | Receivables | Payables  |  |  |
|--------------------------------------|----|-------------|-----------|--|--|
| Trades in process of settlement, net | \$ | 127,636 \$  |           |  |  |
| Margin                               |    | 268,423     | 962,166   |  |  |
| Clearing organizations               |    | 56,103      | 388,040   |  |  |
| Other                                |    | 31,954      | 26,661    |  |  |
| Total  \$                            |    | 484,116 \$  | 1,376,867 |  |  |

#### **Note 8. Intangible Assets**

Intangible assets are included in Other assets in the Statement of Financial Condition. The Company has a swap dealer registration of \$1.4 million at November 30, 2024, which is included in identifiable intangible assets.

The Company performed its annual impairment testing of intangible assets with an indefinite useful life, which consists of its swap dealer registration, at August 1, 2024. The Company elected to perform qualitative assessments of its swap dealer registration. In applying the qualitative assessments, the Company concluded that it is not more likely than not this registration is impaired.

{15}------------------------------------------------

## **Note 9. Liabilities Subordinated to Claims of General Creditors**

At November 30, 2024, the Company has outstanding borrowings of \$600.0 million from the Parent under subordinated loan agreements. The subordinated loan agreements consist of the following:

| \$ in millions                                         | Outstanding<br>Amount | Maturity            |  |  |
|--------------------------------------------------------|-----------------------|---------------------|--|--|
| Cash subordinated loan agreement (1) .                 | \$<br>400.0           | October 31,<br>2031 |  |  |
| Revolving note and cash subordination<br>agreement (2) | 200.0                 | May 15, 2035        |  |  |
| Total  .                                               | \$<br>600.0           |                     |  |  |

(1) This agreement bears interest at a rate of 3.25% per annum and automatically extends for additional one year periods, unless specified actions are taken prior to the maturity date by the Company or Parent.

(2) The Company has a ten year, \$500.0 million revolving note and cash subordination agreement which automatically extends for additional one year periods unless specified actions are taken prior to the maturity date by the Company or Parent. Amounts borrowed under this agreement bear interest at a rate agreed at the time of the advance and are to be repaid in full by May 15, 2035.

On May 15, 2024, the Company entered into a \$500.0 million revolving note and cash subordination agreement with its Parent maturing on May 15, 2035. On June 14, 2024, the Company borrowed \$200.0 million from the revolving subordinated note facility in exchange for a capital distribution to its Parent. On January 15, 2025, the Company repaid \$50.0 million of the outstanding amount under the revolving note and cash subordination agreement.

Amounts borrowed by the Company under the subordinated loan agreement have been approved by the SEC, and therefore, qualify as capital in computing net capital under SEC Rule 18a-1 (Net Capital) under the Act. To the extent that such borrowings are required for the Company's continued compliance with minimum net capital requirements, they may not be repaid.

#### **10. Income Taxes**

The Company's results of operations are included in the consolidated Federal and applicable state combined or unitary income tax returns filed by the Parent. The Company accounts for income taxes using the separate return method with benefitsfor-loss. The Parent will reimburse the Company for losses irrespective of whether the Company would utilize losses on a separate return basis. In states that neither accept nor require combined or unitary tax returns, the Company files separate state income tax returns.

Deferred income tax assets and liabilities are provided for temporary differences between the tax basis of an asset or liability and its reported amount in the Statement of Financial Condition. These temporary differences result in taxable or deductible amounts in future years and are measured utilizing tax rates that will be in effect when such differences are expected to reverse.

Cumulative tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities:

| \$ in thousands                                      | November 30, 2024 |       |  |  |
|------------------------------------------------------|-------------------|-------|--|--|
| Deferred tax assets:                                 |                   |       |  |  |
| Bad debt reserve                                     | \$                | 7,137 |  |  |
| Other assets                                         |                   | 45    |  |  |
| Total deferred tax assets  .                         |                   | 7,182 |  |  |
| Deferred tax liabilities:                            |                   |       |  |  |
| Other liabilities                                    |                   | 380   |  |  |
| Total deferred tax liabilities  .                    |                   | 380   |  |  |
| Net deferred tax asset, included in Other assets  \$ |                   | 6,802 |  |  |

Management believes it is more likely than not that the Company will generate sufficient taxable income in the future to realize the deferred tax asset and therefore, no valuation allowance has been recorded at November 30, 2024.

As of November 30, 2024, the Company has not recorded any unrecognized tax benefits. Per the tax sharing agreement between the Parent and the Company, the Parent records unrecognized tax benefits for positions it takes on the consolidated federal and any combined state and local tax returns and assumes the potential risk or benefit arising from the establishment of such unrecognized tax benefits.

Earliest tax years that remain subject to examination in the major tax jurisdictions in which the Company operates:

| Jurisdiction   | Tax Year |
|----------------|----------|
| United States  | 2021     |
| New Jersey     | 2018     |
| New York State | 2011     |
| New York City  | 2011     |

#### **Note 11. Guarantees**

Derivative Contracts - Certain derivative contracts that the Company has entered into meet the accounting definition of a guarantee under U.S. GAAP. Such derivative contracts include written foreign currency options and written equity put options. On certain of these contracts, such as foreign currency options, the maximum payout on these contracts cannot be quantified since the increase in foreign currency rates are not contractually limited by the terms of the contract. As such, the Company has disclosed notional values as a measure of the maximum potential payout under these contracts.

{16}------------------------------------------------

Notional amounts associated with the Company's derivative contracts meeting the definition of a guarantee under U.S. GAAP at November 30, 2024:

| \$ in millions                               |             | Expected Maturity Date |                  |  |                  |  |                   |
|----------------------------------------------|-------------|------------------------|------------------|--|------------------|--|-------------------|
| Guarantee Type:                              | 2025        | 2026                   | 2027 and<br>2028 |  | 2029 and<br>2030 |  | Total<br>Notional |
| Derivative contracts - non<br>credit related | \$ 16.266.0 | \$ 17.355.7 \$ 4.174.9 |                  |  | \$               |  | 1.5 \$ 37.798.1   |
| Total derivative contracts                   | \$ 16,266.0 | \$17,355.7 \$ 4,174.9  |                  |  | \$               |  | 1.5 \$ 37,798.1   |

It is management's belief that notional amounts generally overstate expected payout and that fair value of these contracts is a more relevant measure of the Company's obligations. At November 30, 2024, the fair value of derivative contracts meeting the definition of a guarantee is a liability of approximately \$74.9 million. The Company substantially mitigates its exposure to market risk on these contracts through hedges, such as other derivative contracts and/or cash instruments. The Company manages risk associated with derivative contracts meeting the definition of a guarantee consistent with its risk management policies.

# **Note 12. Risk Management**

Risk is an inherent part of the Company's business and activities. Risks are managed by the Risk Management group of the Company's Parent. Accordingly, the Company has a comprehensive risk management approach, with a formal governance structure and processes to identify, assess, monitor and manage risk. Principal risks involved in the Company's business activities include market, credit, operational and model risk.

# **Market Risk**

Market risk is defined as the risk of loss due to fluctuations in the market value of financial assets and liabilities attributable to changes in market variables. Market risk is identified, measured, monitored and controlled by diversifying exposures, controlling position sizes, and establishing economic hedges in related securities or derivatives. The Company's market risk principally arises from underlying price, market liquidity, interest rates, credit spreads and foreign currency rates.

# **Counterparty Credit Risk**

Counterparties to the Company's proprietary transactions are primarily institutional clients. Credit risk is the risk of loss due to adverse changes in a counterparty's credit worthiness or its ability or willingness to meet its financial obligations in accordance with the terms and conditions of a financial contract. The Company is exposed to credit risk as a trading counterparty to other broker-dealers and clients, as a holder of securities and as a member of exchanges and clearing organizations. Credit losses could arise should counterparties fail to perform under the terms of the contracts and the value of collateral, to the extent there is any, proves inadequate. The Company manages credit risk by dealing with creditworthy counterparties, monitoring net exposure to individual counterparties, monitoring compliance with established credit limits, and obtaining collateral where appropriate.

# **Concentration of Credit Risk**

Concentrations of credit risk exist for groups of counterparties when they have similar economic characteristics that would cause their ability to meet obligations to be similarly affected by economic, industry or geographic factors. In its trade facilitation activities, the Company is actively involved in trading with a broad range of institutional clients. The Company's exposure to credit risk associated with the nonperformance of these counterparties in fulfilling their contractual obligations can be directly impacted by volatile trading markets which may impair the counterparties' abilities to satisfy their obligations to the Company. From time to time the Company may have significant exposure to specific counterparties, but the Company monitors and manages its exposure and seeks to control its concentration of credit risk through a variety of reporting and control procedures described in preceding discussions of market and credit risk.

# **Operational Risk**

Operational risk refers to the risk of loss resulting from the Company's operations, including, but not limited to, improper or unauthorized execution and processing of transactions, deficiencies in its operating systems, business disruptions and inadequacies or breaches in its internal control processes. The Company's business is highly dependent on its ability to process, on a daily basis, a large number of transactions across numerous and diverse markets in many currencies. The Company relies primarily on its affiliate, Jefferies LLC, for operational support or services in connection with its swaps business. The Company does not have any employees. Jefferies LLC provides services to the Company under a service level agreement. As a result, from a practical perspective, the Company is wholly dependent on Jefferies LLC and its employees to run its swaps business. The Company's operational risk framework includes governance, collection of operational risk incidents, proactive operational risk management, and periodic review and analysis of business metrics to identify and recommend controls and process-related enhancements.

# **Mode/Risk**

Model risk refers to the risk of losses resulting from decisions that are based on the output of models, due to errors or weaknesses in the design and development, implementation, or improper use of models. The Company uses quantitative models primarily to value certain financial assets and liabilities and to monitor and manage its risk. Model risk is a function of the model materiality, frequency of use, complexity and uncertainty around inputs and assumptions used in a given model. Robust model risk management is a core part of the Company's risk management approach and is overseen through its risk governance structure and risk management controls.

{17}------------------------------------------------

#### **Note 13. Related Party Transactions**

Balances with related parties reflected in the Statement of Financial Condition:

| \$ in thousands                                                 | November 30,<br>2024 |
|-----------------------------------------------------------------|----------------------|
| Assets:                                                         |                      |
| Securities purchased under agreements to resell                 | \$<br>282,248        |
| Receivables - Brokers, dealers and clearing<br>organizations    | 394,074              |
| Receivables - Fees, interest and other                          | 1,865                |
| Receivables - Due from affiliates                               | 240                  |
| Liabilities:                                                    |                      |
| Financial instruments sold, not yet purchased, at fair<br>value | \$<br>654            |
| Securities loaned                                               | 2,179                |
| Securities sold under agreements to repurchase                  | 6,360                |
| Payables - Brokers, dealers and clearing organizations .        | 58,135               |
| Payables - Due to Parent and affiliates                         | 324,974              |
| Accrued expenses and other liabilities                          | 817                  |

#### **SMBC**

The Parent has a strategic alliance with Sumitomo Mitsui Financial Group, Inc., Sumitomo Mitsui Banking Corporation ("SMBC") and SMBC Nikko Securities Inc. (together referred to as "SMBC Group") to collaborate on corporate and investment banking business opportunities as well as equity sales, trading and research.

The following tables summarize balances with SMBC as reported in the Company's Statement of Financial Condition and Statement of Operations. In addition, the synergies and value creation resulting from the Parent's strategic alliance with SMBC generate additive benefits for the Company, which are not necessarily reflected by the activity presented in the following tables.

| \$ in thousands                               | November 30,<br>2024 |
|-----------------------------------------------|----------------------|
| Assets                                        |                      |
| Cash and cash equivalents                     | \$<br>500,000        |
| Receivables:                                  |                      |
| Fees, interest and other                      | 1,308                |
| Total assets  \$                              | 501,308              |
|                                               |                      |
| Liabilities                                   |                      |
| Payables:                                     |                      |
| Brokers, dealers and clearing organizations . | 12,000               |
| Total liabilities  \$                         | 12,000               |

#### **Note 14. Regulatory Requirements**

#### **Net Capital**

The Company is registered as an OTC derivatives dealer, a security-based swap dealer and a swap dealer and, accordingly, is subject to the net capital requirements of the SEC, CFTC and NFA. The Company is required to maintain minimum net capital, as defined under SEC Rule 18a-1, of not less than the greater of 2% of the risk margin amount, as defined, or \$20 million. At November 30, 2024, the Company had net capital, as defined under such rules, of \$348.6 million, which exceeded the SEC minimum regulatory capital requirement by \$325.5 million. In addition, the Company is required to maintain minimum net capital, as defined under CFTC Regulation 23.101 of not less than the greater of 2% of the risk margin amount, as defined, or \$20 million. At November 30, 2024, the Company had net capital, as defined under such rules, of \$348.6 million, which exceeded the CFTC minimum regulatory capital requirement by \$322.1 million.

In addition, advances to the Parent and its affiliates, capital distributions and other equity withdrawals are subject to certain notification requirements and other provisions of the SEC, CFTC and NFA.

#### **Customer Protection and Segregation Requirement**

The Company does not engage in cleared swap and securitybased swap activity on behalf of its counterparties. For its uncleared swap and security-based swap transactions with its counterparties where the Company is required to collect margin, the Company applies the segregation exemption pursuant to CFTC Regulation 23.701 and SEC Rule 18a-4(f)(2) and (3). Therefore, any margin collateral received and held by the Company with respect to uncleared swap and security-based swap transactions will not be subject to segregation requirements.


Source: SEC EDGAR via Adviser Search (https://search.stillhousedata.com). Agents: see https://search.stillhousedata.com/llms.txt.
